Latest Trials

EudraCT Number: 2013-005429-21 Sponsor Protocol Number: OPTIMIST-Aprotocol Start Date:
Sponsor Name: Menzies Research Institute Tasmania
Full Title: Multicentre randomised controlled trial of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation on continuous positive airway pressure (CPAP)
Medical condition: Infant respiratory distress syndrome, also known as hyaline membrane disease.
Disease: Version SOC Term Classification Code Term Level
18.0 100000004855 10020477 Hyaline membrane disease LLT
Population Age: In utero, Preterm newborn infants, Under 18 Gender: Male, Female
Trial protocol: GB (GB - no longer in EU/EEA) Outside EU/EEA SI (Ongoing) NL ()
Trial results: (No results available)
EudraCT Number: 2008-008689-11 Sponsor Protocol Number: 3/15.12.2008 Start Date:
Sponsor Name: Children's Memorial Health Institute
Full Title: Efficacy and safety of omega – 3 based lipid solution (Omegaven) in comparison with Lipofundin LCT/MCT in reducing cholestasis in children on parenteral nutrition – randomized double – blind clinic...
Medical condition: Parenteral nutrition associated liver disease (PNALD) MedDRA LLT: total parenteral nutrition MedDRA PT: parenteral nutrition MedDRA LLT: liver cholestasis MedDRA PT: cholestasis
Disease: Version SOC Term Classification Code Term Level
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: PL (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2020-002372-13 Sponsor Protocol Number: SRP-9001-303 Start Date:
Sponsor Name: Sarepta Therapeutics, Inc.
Full Title: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of SRP-9001 in Non-Ambulatory and Ambulatory Subjects...
Medical condition: Duchenne Muscular Dystrophy
Disease: Version SOC Term Classification Code Term Level
20.1 10010331 - Congenital, familial and genetic disorders 10052655 Duchenne muscular dystrophy gene carrier PT
20.0 10010331 - Congenital, familial and genetic disorders 10013801 Duchenne muscular dystrophy PT
Population Age: Children, Adolescents, Under 18, Adults Gender: Male
Trial protocol: FR (Ongoing) SE (Ongoing) IT (Ongoing) ES (Ongoing) BE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2014-004897-40 Sponsor Protocol Number: GABA-2 Start Date:
Sponsor Name: PHARM – Pharmaceutical Research Management srl
Full Title: Randomized, double-blind, placebo controlled, multi-centre, superiority phase II study to evaluate the safety, pharmacokinetic, efficacy of gabapentin liquid formulation as add-on to morphine in ch...
Medical condition: Chronic pain of neuropathic or mixed origin
Disease: Version SOC Term Classification Code Term Level
19.1 100000004852 10054095 Neuropathic pain LLT
Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: DE (Prematurely Ended) FR (Ongoing) NL (Prematurely Ended) IT (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2021-002339-44 Sponsor Protocol Number: IGM-2323-001 Start Date:
Sponsor Name: IGM Biosciences, Inc.
Full Title: A Phase 1/2 Open-Label, Multicenter Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of IGM-2323 in Subjects with Relapsed/Refractory Non-Hodgkin Lymphomas
Medical condition: Relapsed/Refractory (R/R) Non-Hodgkin lymphomas (NHL)
Disease: Version SOC Term Classification Code Term Level
23.0 100000004864 10025311 Lymphoma (non-Hodgkin's) LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Completed) ES (Ongoing) IT (Ongoing) DK (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2010-018781-23 Sponsor Protocol Number: 2917800009 Start Date:
Sponsor Name: Top Institute Food and Nutrition
Full Title: Diagnose of GH-deficiency: comparing the dietary-protein test with conventional Growth Hormone Stimulation Tests
Medical condition: To investigate if there is a correlation between the peak GH concentrations after ingestion of gelatin protein and the peak GH concentrations after the two standard tests (GHST) in order to discrim...
Disease: Version SOC Term Classification Code Term Level
12.1 10056438 Growth hormone deficiency LLT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2015-003509-41 Sponsor Protocol Number: GBG90 Start Date:
Sponsor Name: GBG Forschungs GmbH
Full Title: A randomized phase II trial to assess the efficacy of paclitaxel and olaparib in comparison to paclitaxel / carboplatin followed by epirubicin/cyclophosphamide as neoadjuvant chemotherapy in patien...
Medical condition: Patients with triple negative or HRpositive, early breast cancer
Disease: Version SOC Term Classification Code Term Level
20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10006187 Breast cancer PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)
EudraCT Number: 2015-002882-41 Sponsor Protocol Number: AIBDSG_002 Start Date:
Sponsor Name: Medical University of Vienna (MUW)
Full Title: Sono-­Response-­Study A Pilot Study on the use of contrast enhanced ultrasound in Crohn’s disease
Medical condition: Inflammatory bowel disease (Crohn's disease)
Disease: Version SOC Term Classification Code Term Level
18.1 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2010-024094-39 Sponsor Protocol Number: Adip-2010 Start Date:
Sponsor Name: University of Ulm, University Hospital Ulm
Full Title: Offene, monozentrische, nicht kontrollierte und nicht randomisierte Phase IV-Studie zur Bestimmung der Pharmakokinetik von Carbapenemen in adipösen Patienten.
Medical condition: The purpose of this study is to determine the free tissue kinetics of ertapenem and meropenem in fatty tissue and intraperitoneal fluid up to 24 hours after administration of the IMP. Subjects are ...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2005-003023-40 Sponsor Protocol Number: 21805 Start Date:
Sponsor Name: Food Standards Agency
Full Title: The role of peanut specific T cell responses in children with peanut allergy and in children who are tolerant to peanuts
Medical condition: Children with Peanut Allergy
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: GB (GB - no longer in EU/EEA)
Trial results: (No results available)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe